Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort stu
about
Risk-Benefit Profile of Direct-Acting Oral Anticoagulants in Established Therapeutic Indications: An Overview of Systematic Reviews and Observational StudiesReal Data on Effectiveness, Tolerability and Safety of New Oral Anticoagulant Agents: Focus on Dabigatran.Comparing Stroke and Bleeding with Rivaroxaban and Dabigatran in Atrial Fibrillation: Analysis of the US Medicare Part D Data.Data Resource Profile: The French National Uniform Hospital Discharge Data Set Database (PMSI).Geriatric Patient Safety Indicators Based on Linked Administrative Health Data to Assess Anticoagulant-Related Thromboembolic and Hemorrhagic Adverse Events in Older Inpatients: A Study Proposal.Exchangeable Femoral Neck (Dual-Modular) THA Prostheses Have Poorer Survivorship Than Other Designs: A Nationwide Cohort of 324,108 Patients.Bleeding outcomes associated with rivaroxaban and dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysis.Identifying atrial fibrillation in outpatients initiating oral anticoagulants based on medico-administrative data: results from the French national healthcare databases.Bleeding events associated with a low dose (110 mg) versus a high dose (150 mg) of dabigatran in patients treated for atrial fibrillation: a systematic review and meta-analysisA population database study of outcomes associated with vitamin K antagonists in atrial fibrillation before DOAC.Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation.Comparative effectiveness and safety of oral anticoagulants for atrial fibrillation in real-world practice: a population-based cohort study protocolShort-Term Risk of Bleeding During Heparin Bridging at Initiation of Vitamin K Antagonist Therapy in More Than 90 000 Patients With Nonvalvular Atrial Fibrillation Managed in Outpatient CareLong-term follow-up after bariatric surgery in a national cohort.Risk of major bleeding in patients with non-valvular atrial fibrillation treated with oral anticoagulants: a systematic review of real-world observational studies.The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohortDirect oral anticoagulants: unique properties and practical approaches to management.Left atrial appendage closure: outcomes and challengesClinical outcomes and direct costs after transcatheter aortic valve implantation in French centres: a longitudinal study of 1332 patients using a national database.Sex-Specific Comparative Effectiveness of Oral Anticoagulants in Elderly Patients With Newly Diagnosed Atrial Fibrillation.Outcomes in patients after myocardial infarction similar to those of the PEGASUS-TIMI 54 trial: A cohort study in the French national claims database.Direct Oral Anticoagulants Form Thrombus Different From Warfarin in a Microchip Flow Chamber System.Real-world comparison of all-cause hospitalizations, hospitalizations due to stroke and major bleeding, and costs for non-valvular atrial fibrillation patients prescribed oral anticoagulants in a US health plan.Real-world Data and Recommended Dosage of Non-vitamin K Oral Anticoagulants for Korean Patients.Association of Atrial Fibrillation and Oral Anticoagulant Use With Perioperative Outcomes After Major Noncardiac Surgery.Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes.Effectiveness and safety of oral anticoagulants in older patients with atrial fibrillation: a systematic review and meta-regression analysis.Association Between Use of Antithrombotic Medication and Hematuria-Related Complications.Association Between Bariatric Surgery and Rates of Continuation, Discontinuation, or Initiation of Antidiabetes Treatment 6 Years Later.Safety and Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists: Pilot Implementation of a Near-Real-Time Monitoring Program in Italy.Bleeding-related hospital admissions and 30-day readmissions in patients with non-valvular atrial fibrillation treated with dabigatran versus warfarin.Real-world effectiveness and safety of oral anticoagulation strategies in atrial fibrillation: a cohort study based on a German claims dataset.Relative impact of hospital and surgeon procedure volumes on primary total hip arthroplasty revision: a nationwide cohort study in France.
P2860
Q28078747-1E39D7F0-88BE-4887-95FA-F90294648368Q31098679-EAD73283-A0AC-4715-9F07-EC834FF23BBDQ31131255-2E94FD9C-0D9D-4824-8F24-F8BC3B74E43FQ31160044-BB012F38-2658-49D1-AD19-091F7F830B98Q33729805-52CAAA29-8791-4127-9A0C-75E5AC0C3958Q33874996-7E39582B-5EF5-456A-9425-29CA9F1557F2Q36240734-556E7A54-1474-487F-B0FA-1D98874D6F28Q36308658-91C5EBFC-CF0F-4CC9-9605-BBA14E472909Q36309584-F70AEBEA-BBE8-42AD-90E1-00A8C8448923Q36618123-67430185-EC27-41CF-BDCF-5762F0019D48Q37076243-FD80A45F-C830-49F5-9B37-3E0B64DB58EFQ37527133-C2437A00-5B6A-4E67-9AE1-023857D08890Q37556151-99AE7381-A564-41BB-A1E1-90E0594AD6DAQ38705488-D16FF07F-7310-4CBC-BDCE-C03A54BA3D44Q38712351-67151590-6234-48E6-BBB5-635D877E8A2BQ38764020-226BC244-F1CD-4052-B2BD-78DD0CE3A809Q38847232-1074320F-8DE0-4C0A-B698-3C78E162294CQ38893463-F8B82A7D-6502-4E83-98FE-E46750D48A60Q39036222-9924EA69-B3E3-4EC5-8EEA-45C4087E7229Q39417014-1363760A-6B7D-4775-A921-73A96F2DDBD0Q40242892-782313B7-39C5-48C8-8AB2-9D7D0DE98ADFQ40272818-F4AAD5BE-760A-4E64-8934-5A95D1021379Q41286371-4F8C0DB8-8F67-4E3F-A326-93EC942C675DQ46050727-6C88EDB6-4DCF-43C9-9788-58E8B127F251Q47114806-B2A97142-97D2-4FAC-A95A-D56B0505B590Q47221597-05B400BC-AF27-4A23-BB15-2A757ADF3AF2Q47648468-1DE74D64-904E-4BD3-958D-B0A7BED917D6Q49557387-8FB22363-52C8-4185-A6B0-449498C9075FQ49653415-FF5776B4-FDBB-4CC8-8215-17BBE5CA6679Q49951864-E07D5440-2BE2-484E-9429-1A93B46AE697Q51741687-58ABE0DA-5DCF-4E38-9817-7351B4FD5DC1Q53140080-8AC3106E-6B3D-4FF5-A7EE-E19018B1E404Q54975650-96B26AC3-F840-4132-8CF1-3015C78BFF4DQ55513243-8A35C8E5-95E2-4619-8D17-3C45FC1F90C4
P2860
Comparison of the short-term risk of bleeding and arterial thromboembolic events in nonvalvular atrial fibrillation patients newly treated with dabigatran or rivaroxaban versus vitamin K antagonists: a French nationwide propensity-matched cohort stu
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Comparison of the short-term r ...... propensity-matched cohort stu
@en
type
label
Comparison of the short-term r ...... propensity-matched cohort stu
@en
prefLabel
Comparison of the short-term r ...... propensity-matched cohort stu
@en
P2093
P2860
P50
P921
P1433
P1476
Comparison of the short-term r ...... propensity-matched cohort stu
@en
P2093
Cécile Billionnet
Kim Bouillon
Philippe Ricordeau
Pierre-Olivier Blotière
P2860
P304
P356
10.1161/CIRCULATIONAHA.115.015710
P407
P577
2015-07-21T00:00:00Z